|
May 11
|
1 No-Brainer Growth Stock to Buy and Hold
|
|
May 11
|
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
|
|
May 10
|
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
|
|
May 10
|
How A Top Fund Beats The Market By Owning Future Leaders
|
|
May 10
|
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
|
|
May 10
|
Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
|
|
May 10
|
UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
|
|
May 9
|
Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
|
|
May 9
|
3 Stocks to Buy Following Guidance Upgrades
|
|
May 9
|
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
|
|
May 8
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 7
|
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
|
|
May 7
|
A Look at Pharma ETFs Post Q1 Earnings
|
|
May 7
|
13 Best Stocks That Will Always Grow
|
|
May 7
|
Kevin O’Leary’s Stock Portfolio: 10 Stock Picks for 2024
|
|
May 7
|
UPDATE 2-US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
|
|
May 7
|
Mutual Funds Can't Get Enough Amazon, Broadcom
|
|
May 7
|
FDA sets date for advisory meeting on Lilly’s closely watched Alzheimer’s drug
|
|
May 6
|
Why Eli Lilly Stock Jumped by 4% Today
|